Literature DB >> 2437155

Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides.

M Pollack, A A Raubitschek, J W Larrick.   

Abstract

Epstein-Barr virus (EBV)-transformed human B lymphocytes were fused with a murine-human heteromyeloma to produce stable hybrid cell lines that secreted human monoclonal antibodies (mAbs) of the IgM class that recognized conserved epitopes in the core-lipid A region of lipopolysaccharides (LPS). Three of the mAbs reacted with epitopes on the lipid A moiety, while a fourth recognized a determinant in the core oligosaccharide. The lipid A-specific mAbs cross-reacted with heterologous rough LPS and with lipid As released by acid hydrolysis of different intact (smooth) LPS. Carbohydrate groups in the O-side chain and core oligosaccharide of isolated, smooth LPS restricted antibody access to antigenic sites on lipid A. Yet, one lipid A-reactive mAb recognized its epitope on the surfaces of a variety of intact bacteria. These findings confirm the presence of highly conserved epitopes in the core-lipid A complex and prove the existence of human B cell clones with the potential for secreting high avidity IgM antibodies that react with these widely shared determinants. Such human mAbs might provide protective activity against disease caused by diverse gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437155      PMCID: PMC424413          DOI: 10.1172/JCI112970

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.

Authors:  S K Foung; S Perkins; A Raubitschek; J Larrick; G Lizak; D Fishwild; E G Engleman; F C Grumet
Journal:  J Immunol Methods       Date:  1984-05-11       Impact factor: 2.303

2.  Transformation by subgenomic fragments of Rous sarcoma virus DNA.

Authors:  N G Copeland; A D Zelenetz; G M Copper
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

3.  Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.

Authors:  L M Mutharia; G Crockford; W C Bogard; R E Hancock
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium.

Authors:  N Qureshi; K Takayama; E Ribi
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

5.  Fatty acyl derivatives of glucosamine 1-phosphate in Escherichia coli and their relation to lipid A. Complete structure of A diacyl GlcN-1-P found in a phosphatidylglycerol-deficient mutant.

Authors:  K Takayama; N Qureshi; P Mascagni; M A Nashed; L Anderson; C R Raetz
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

6.  Lipopolysaccharides: structural principles and biologic activities.

Authors:  O Lüderitz; K Tanamoto; C Galanos; G R McKenzie; H Brade; U Zähringer; E T Rietschel; S Kusumoto; T Shiba
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

7.  Concepts of the chemical structure of lipid A.

Authors:  E T Rietschel; H W Wollenweber; R Russa; H Brade; U Zähringer
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

8.  Enzymatic deacylation of the lipid A moiety of Salmonella typhimurium lipopolysaccharides by human neutrophils.

Authors:  C L Hall; R S Munford
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.

Authors:  M Pollack; A I Huang; R K Prescott; L S Young; K W Hunter; D F Cruess; C M Tsai
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

View more
  16 in total

Review 1.  Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.

Authors:  J D Baumgartner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

Review 3.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

4.  Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides.

Authors:  J de Jongh-Leuvenink; J Schellekens; J Verhoef
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

5.  Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Authors:  S A Siegel; M E Evans; M Pollack; A O Leone; C S Kinney; S H Tam; P E Daddona
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Pollack; N L Koles; M J Preston; B J Brown; G B Pier
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Studies of the specificity and cross-reactions of antibodies to lipid A found in juvenile arthritis.

Authors:  J J Miller; L C Olds
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.

Authors:  P S Leung; S Krams; S Munoz; C P Surh; A Ansari; T Kenny; D L Robbins; J Fung; T E Starzl; W Maddrey
Journal:  J Autoimmun       Date:  1992-12       Impact factor: 7.094

10.  Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Authors:  M A Mascelli; B Frederick; T Ely; D S Neblock; D J Shealy; K Y Pak; P E Daddona
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.